Peptide self-experimentation on TikTok: what the science says

What did @jacobnach actually say?

Jacob announced he's stacking three peptides simultaneously: Melanotan II (which he calls "Milano Tantu"), KPV, and GHK-Cu, branding it his "dream stack for any skin peptide users." He claims this combination has never been done before, describes Melanotan II as the "Barbie drug" that makes you "skinny, tan, and a little bit horny," calls KPV the "master anti-inflammatory," and credits GHK-Cu with collagen and hair, skin, and nail benefits. He reported noticing more color after just one day of Melanotan II use before sun exposure. He frames the whole thing as personal scientific experimentation.

To his credit, he didn't claim to be treating any disease and was transparent that he's essentially a self-experimenter. He did say he'd cover each compound separately, which suggests he's not trying to compress nuanced pharmacology into a single clip. That's a lower bar, but it's worth noting.

Does the science back this up?

Partially, but unevenly across the three compounds. GHK-Cu has the strongest published evidence of the three. KPV has real preclinical data. Melanotan II has the shakiest safety profile and the most overstated claims in this video.

GHK-Cu (copper peptide GHK) has been studied for wound healing, collagen synthesis stimulation, and antioxidant activity. Pickart and Margolina (2018, Biomolecules) summarized evidence showing GHK-Cu upregulates collagen and glycosaminoglycan synthesis in skin fibroblasts. Topical and subcutaneous applications have shown measurable effects in small human trials, though large randomized controlled trials are sparse.

KPV is a tripeptide fragment of alpha-MSH with documented anti-inflammatory properties in preclinical models. Kannengiesser et al. (2008, Peptides) showed KPV reduced intestinal inflammation in murine colitis models. Its skin-specific anti-inflammatory evidence is largely in vitro or animal-based. Calling it the "master anti-inflammatory" is an overreach given the evidence base.

Melanotan II is where the science gets complicated and the risk profile gets real. It does activate MC1R to stimulate melanogenesis, producing a tan. It also activates MC4R, which explains the appetite suppression and sexual side effects Jacob jokes about. Studies have linked it to nausea, spontaneous erections, facial flushing, and concerning reports of melanoma activation in predisposed individuals (Cantrell, 2010, Annals of Emergency Medicine).

What did they get wrong (or right)?

The biggest problem here is what Jacob glosses over with the phrase "a little bit horny." Melanotan II's off-target receptor activity is not a quirky side effect. It produces priapism in some users, has caused hospitalizations, and is not approved by the FDA or any major regulatory body for any indication. Framing it as fun and harmless is misleading.

He's also wrong that "I've never seen anybody do this stack before" should be read as a reason to try it. The absence of prior documentation isn't a green light. It means there's no safety data on combined use. These three compounds have different routes of action and different receptor targets, but stacking them without any pharmacokinetic or interaction data is not science. It's anecdote collection.

Where he's accurate: GHK-Cu's role in collagen and skin health is genuinely supported by published research. KPV does have legitimate anti-inflammatory data, even if "master anti-inflammatory" is marketing language, not a scientific classification. His willingness to label himself a self-experimenter rather than a medical authority is at least honest framing.

What should you actually know?

These peptides are not FDA-approved for cosmetic or skin use. They are research compounds. In the U.S., they may be available through compounding pharmacies under specific prescriber oversight, but that's a clinical conversation, not a TikTok stack.

Melanotan II specifically has been flagged by the FDA and the UK's MHRA as an unlicensed medicine with documented safety concerns. The tanning effect is real, but so are the risks, particularly for anyone with a personal or family history of melanoma or dysplastic nevi. The Cantrell case series reported in emergency medicine literature included users who developed rapidly changing moles after Melanotan II use.

KPV and GHK-Cu have substantially better safety profiles in the published literature, but that does not mean they are safe in combination with Melanotan II or at any arbitrary dose. If you're interested in peptide-based skin support, that's a conversation worth having with a clinician who can review your history, not something to replicate from a Labor Day weekend TikTok experiment.

• Melanotan II is not a regulated therapeutic in the U.S. and should not be sourced or used without medical supervision.
• Anyone with moles, skin lesions, or a family history of melanoma should be especially cautious about anything that stimulates melanocyte activity.
• GHK-Cu and KPV have better evidence profiles, but "better than Melanotan II" is a low bar.